Emergent Biosolutions Financials

Values in thousands	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Revenue	$140,900	$222,200	$189,300	$293,800
Gross Profit	57,800	133,700	60,000	164,200
EBITDA	1,600	132,800	13,200	177,100
EBIT		107,400	-12,800	150,700
Net Income	-12,000	68,000	-31,300	114,800
Net Change In Cash	140,900	222,200	189,300	293,800
Free Cash Flow	103,500	-14,800	-81,600	147,900
Cash	267,300	149,100	99,500	149,900
Basic Shares	54,200	57,300	54,200	55,600

Values in thousands	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Revenue	$1,013,600	$1,049,300	$1,120,900	$1,792,700
Gross Profit	305,200	343,900	427,200	1,035,200
EBITDA	36,900	-505,300	-34,400	458,200
EBIT	-71,900	-630,400	-166,000	331,900
Net Income	-190,600	-760,500	-223,800	219,500
Net Change In Cash	1,013,600	1,049,300	1,120,900	1,792,700
Cost of Revenue			65,800	-44,900
Free Cash Flow	35,800	-257,900	-149,900	96,100
Cash	99,500	111,700	642,600	576,100
Basic Shares	53,000	51,200	50,100	54,100